Aaron Noles, MD
Neurology · Fort Walton Beach, FLNPI 1982066346
Payments from drug & device makers
Across 85 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$454
- GRT US Holding, Inc.$139
- Novartis$116
- Amgen$86
- Lundbeck LLC$81
- Lilly USA, LLC$65
- plus $638 from 20 others
What the payments were for
- Food & beverage$1,572100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $454 |
| GRT US Holding, Inc. | 2 | $139 |
| Novartis | 6 | $116 |
| Amgen | 5 | $86 |
| Lundbeck LLC | 4 | $81 |
| Lilly USA, LLC | 4 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $61 |
| Sanofi | 3 | $59 |
| Pfizer | 2 | $53 |
| Genentech USA, Inc. | 2 | $50 |
| Biogen | 3 | $50 |
| Acorda Therapeutics, Inc | 2 | $43 |
| Acadia Pharmaceuticals Inc | 2 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Johnson & Johnson(2 entities) | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Argenx US, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $24 |
| Greenwich Biosciences, Inc. | 1 | $23 |
| CSL Behring | 1 | $20 |
| Grifols USA, LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $14 |
How this compares
$1,579 in reported general payments places this provider in the 40th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Fort Walton Beach
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.